Regents of the University of California’s Biogen BIIB Stock Holding History

Regents of the University of California’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-2,400	Closed	-$1.01M	–	33
2015 Q1	$1.01M	Buy	2,400 +300	+14%	+$118K	1.02%	35
2014 Q4	$713K	Buy	+2,100	New	+$679K	0.71%	66
2013 Q3	–	Sell	-10,855	Closed	-$2.34M	–	82
2013 Q2	$2.34M	Buy	+10,855	New	+$2.32M	1.26%	36

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Regents of the University of California's BIIB Position: Q2 2015 in Review

Regents of the University of California sold out of Biogen (BIIB) in Q2 2015, closing a stake of 2,400 shares — an estimated $1.01M sold.

Regents of the University of California first reported a position in BIIB in Q2 2013 and held it in 3 quarters. The position peaked at $2.34M in Q2 2013. 974 funds tracked by Wall St. Rank hold BIIB as of Q2 2015.

Regents of the University of California reported no remaining Biogen position as of Q2 2015 after selling out during the quarter.
Regents of the University of California sold 2,400 Biogen shares in Q2 2015, an estimated $1.01M.
Regents of the University of California first reported a position in Biogen in Q2 2013 and held it in 3 quarters.
Regents of the University of California's Biogen position peaked at $2.34M in Q2 2013.
974 funds tracked by Wall St. Rank held Biogen as of Q2 2015.

Based on Regents of the University of California's 13F filing for Q2 2015, filed 6 Aug 2015.